DNLI icon

Denali Therapeutics
DNLI

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$30
84% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Cantor Fitzgerald
Cantor Fitzgerald
Josh Schimmer
100% 1-yr DNLI win rate
8 Sep ‘25 1 month ago
Morgan Stanley
Morgan Stanley
Matthew Harrison
50% 1-yr DNLI win rate
18 Aug ‘25 1 month ago